X4 Pharmaceuticals, Inc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q2 2024.
  • X4 Pharmaceuticals, Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 200M shares, a 18.8% increase year-over-year.
  • X4 Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 178M shares, a 180% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 63.5M shares, a 147% increase from 2021.
  • X4 Pharmaceuticals, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 25.7M shares, a 28.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 200M +31.7M +18.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 200M +54M +37% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 178M +114M +180% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 197M +114M +137% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 169M +133M +376% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 146M +112M +333% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 63.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 83.2M +56.6M +213% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 35.4M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 33.7M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 26.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.